SCHEMBL18599284

SCHEMBL18599284

CCCN(C)c1nc(-c2ccnc3c2CCN3)cs1

nearest known ligand 0.32

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ GRM1 Q13255 1/20 0.32
▸ DHODH Q02127 1/20 0.32
▸ LIMK1 P53667 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21974562 0.70 RAB9A (0.48) —
SCHEMBL18678349 0.67 RAB9A (0.54) GRM1
SCHEMBL13685621 0.64 KDM4E (0.41) GRM1
SCHEMBL12127924 0.64 CCR1 (0.48) —
SCHEMBL25933244 0.62 SMN1; SMN2 (0.38) —
SCHEMBL14420773 0.61 HRH3 (0.46) —
SCHEMBL25777808 0.61 MEN1 (0.40) —
SCHEMBL11987587 0.61 HTR2C (0.43) —
SCHEMBL13774787 0.60 CDC7 (0.32) —
SCHEMBL12127868 0.60 PARP10 (0.51) LIMK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2348023-B9 Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as Janus kinase inhibitors INCYTE HOLDINGS CORP (US) 2017-03-08 — — EP disclosed
Send feedback